Long term treatment of myeloproliferativ
β
Harriet S. Gilbert
π
Article
π
1998
π
John Wiley and Sons
π
English
β 96 KB
## BACKGROUND. Recombinant interferon-β£-2b (rIFN-β£-2b) has shown therapeutic potential in patients with chronic myelogenous leukemia and other myeloproliferative disorders (MPDs), including the ability to suppress the abnormal hematopoietic clone and to reverse myelofibrosis. This study was conduc